產(chǎn)品詳情
簡單介紹：
Anti-beta-Amyloid (1-42)抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-beta-Amyloid (1-42)抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Mouse Anti-beta-Amyloid (1-42)
Cat. Number:
Anti-beta-Amyloid (1-42)抗體KL-0107M
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to Anti-beta-Amyloid (1-42)抗體43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid antibodies and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
Also known as:
beta-Amyloid(1-42); A4; AAA; Anti-beta-Amyloid (1-42)抗體ABETA; ABPP; AD1; Alzheimers Disease Amyloid Protein; Amyloid B; Amyloid Beta A4 Protein Precursor; Amyloid Beta; Amyloid of Aging and Alzheimer Disease; APP; APPI; B Amyloid; Beta APP; Cerebral Vascular Amyloid Peptide; CTFgamma; CVAP; PN II; PN2; PreA4; Protease nexin II; A beta; Amyloid 1-42.
Specificity:
●
Mouse Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human beta-Amyloid (1-42).
●
Predicted Molecular Weight: 4.4kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-beta-Amyloid (1-42)抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions mustAnti-beta-Amyloid (1-42)抗體 be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions mustAnti-beta-Amyloid (1-42)抗體 be determined by the end user.
kl771Ra01 趨化因子C-X-C-基元配體16(CXCL16)多克隆抗體 Polyclonal Antibody to Chemokine C-X-C-Motif Ligand 16 (CXCL16)
kl775Hu01 己糖激酶1(HK1)多克隆抗體 Polyclonal Antibody to Hexokinase 1 (HK1)
kl775Mu01 己糖激酶1(HK1)多克隆抗體 Polyclonal Antibody to Hexokinase 1 (HK1)
kl776Hu01 丙酮酸脫氫酶α(PDHα)多克隆抗體 Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl776Mu01 丙酮酸脫氫酶α(PDHα)多克隆抗體 Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl776Ra01 丙酮酸脫氫酶α(PDHα)多克隆抗體 Polyclonal Antibody to Pyruvate Dehydrogenase Alpha (PDHa)
kl777Hu01 T-細(xì)胞可誘導(dǎo)共刺激分子(ICOS)多克隆抗體 Polyclonal Antibody to Inducible T-Cell Co Stimulator (ICOS)
kl778Hu01 B-細(xì)胞**瘤因子2(Bcl2)多克隆抗體 Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Mu01 B-細(xì)胞**瘤因子2(Bcl2)多克隆抗體 Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Po01 B-細(xì)胞**瘤因子2(Bcl2)多克隆抗體 Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl778Ra01 B-細(xì)胞**瘤因子2(Bcl2)多克隆抗體 Polyclonal Antibody to B-Cell Leukemia/Lymphoma 2 (Bcl2)
kl781Hu01 CD276分子(CD276)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 276 (CD276)
kl782Ga01 碳酸酐酶Ⅱ(CA2)多克隆抗體 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl782Hu01 碳酸酐酶Ⅱ(CA2)多克隆抗體 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl783Hu01 補(bǔ)體因子P(CFP)多克隆抗體 Polyclonal Antibody to Complement Factor P (CFP)
kl785Hu01 腎損傷分子1(Kim1)多克隆抗體 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl785Mu01 腎損傷分子1(Kim1)多克隆抗體 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl785Ra01 腎損傷分子1(Kim1)多克隆抗體 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl786Hu01 纖維膠凝蛋白1(FCN1)多克隆抗體 Polyclonal Antibody to Ficolin 1 (FCN1)
kl786Mu01 纖維膠凝蛋白1(FCN1)多克隆抗體 Polyclonal Antibody to Ficolin 1 (FCN1)
